NCT00293891View on ClinicalTrials.gov

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

658

Participants

Timeline

Start Date

Not specified

Study Completion Date

January 31, 2007

Conditions
Psoriasis
Interventions
DRUG

Tacrolimus Cream

Trial Locations (33)

10032

New York

23507

Norfolk

27710

Durham

30263

Newnan

33144

Miami

33407

West Palm Beach

35205

Birmingham

37917

Knoxville

40217

Louisville

43212

Columbus

45408

Dayton

46256

Indianapolis

48060

Port Huron

48109

Ann Arbor

53209

Milwaukee

63110

St Louis

68144

Omaha

72205

Little Rock

75390

Dallas

77058

Houston

78229

San Antonio

80246

Denver

84132

Salt Lake City

92123

San Diego

98101

Seattle

01845

North Andover

Unknown

Portland

T2S 3B3

Calgary

T5J 3S9

Edmonton

V3R

Surrey

E1C 8X3

Moncton

H7S 2C6

Laval

H2K 4L5

Montreal

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT00293891 - A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis | Biotech Hunter | Biotech Hunter